MedVi vs Directmeds: Semaglutide, Pricing, and Support
MedVi vs Directmeds is a comparison of two telehealth brands that both offer compounded GLP-1 medications online. Quick verdict: MedVi emphasizes a simple, no-clinic process with 24/7 certified medical support and a promotional first month at $179, while Direct Meds advertises a lower promotional start at $147 and adds injectable and sublingual options plus tirzepatide in its standard pricing.
How pricing and promotions compare
Both providers present promotional starting prices but differ in ongoing costs and stated standard rates. MedVi’s landing page shows a winter promotional first month at $179 including fast, free shipping, but notes the standalone month price rises to $299 and a three-month plan is $649. Direct Meds advertises a promotional starting price of $147 and its FAQ lists standard pricing of $297/month for semaglutide and $399/month for tirzepatide. These are the platform prices reported on each source page.
Medication types and formats available
MedVi focuses on compounded semaglutide only, while Direct Meds offers compounded semaglutide and tirzepatide. Direct Meds also advertises both injectable and sublingual formats. MedVi’s evidence repeatedly references clinically dosed compounded semaglutide and does not list tirzepatide or sublingual forms.
Support, clinician review, and clinical process
MedVi emphasizes a simple online intake with no clinic visits and 24/7 certified medical support; prescriptions are produced via licensed pharmacies and an OpenLoop Health clinician reviews eligibility post-checkout. Direct Meds similarly provides clinician review, telehealth visits, and ongoing clinician and nursing support. Both platforms state that treatment is only available when a licensed clinician determines it is medically appropriate.
Shipping, cancellation, and membership differences
MedVi’s promo includes fast, free shipping and says medication is included in program costs; its materials also reference membership messaging and a three-month plan option. Direct Meds advertises free temperature-controlled 1 to 2 day shipping with UPS or FedEx, no separate monthly membership fee, and a month-to-month cancellation policy for standard plans, while subscribe-and-save plans require the stated term. Direct Meds also notes a full refund if a prescription is not approved. MedVi notes that prescriptions are cash-pay and insurance may reimburse branded options, and states compounded medications are not FDA-approved.
Start Direct Meds at $147 promo
Regulatory and availability notes
Both providers state their compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Direct Meds specifically lists geographic limits, noting it is not available in Mississippi or Louisiana. MedVi’s materials warn that compounded medications are not FDA-approved and that OpenLoop Health clinicians decide whether to prescribe compounded GLP-1s.
| Criteria | MedVi | Direct Meds |
|---|---|---|
| Promotional starting price | $179 first month, fast free shipping | $147 promotional start |
| Standard pricing | Standalone month $299; three-month plan $649 | FAQ: semaglutide $297/mo; tirzepatide $399/mo |
| Medication options | Compounded semaglutide only | Compounded semaglutide and tirzepatide; injectable and sublingual |
| Support and care model | Simple online intake, no clinic visits, 24/7 certified medical support | Clinician review, telehealth visits, ongoing clinician and nursing support |
| Shipping and fees | Fast, free shipping; medication included in program cost | Free temperature-controlled 1 to 2 day shipping; no separate membership fee |
| Availability and limits | Uses licensed pharmacies; clinicians decide eligibility | Not available in Mississippi or Louisiana; full refund if prescription not approved |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved |
What matters most for most patients
If promotional price and a fully online, no-clinic process matter most, MedVi highlights a winter promo at $179 and a clear no-clinic workflow plus 24/7 certified medical support. If you want a lower headline promotion, access to tirzepatide, or sublingual formats, Direct Meds specifies a $147 promotional start and lists both injectable and sublingual options plus standard pricing for tirzepatide. Both providers require clinician review and both note compounded medications are not FDA-approved.
Conclusion: MedVi vs Directmeds
MedVi vs Directmeds comes down to tradeoffs between a promoted simple no-clinic program with 24/7 support and a platform that advertises a lower promotional price plus additional medication types and formats. MedVi: promoted first month $179, compounded semaglutide, no clinic visits, 24/7 certified medical support. Direct Meds: promoted start $147, compounded semaglutide and tirzepatide, injectable and sublingual forms, no separate membership fee, and free next-day temperature-controlled shipping.
Choose MedVi if you want a simple online intake, no clinic visits, 24/7 certified medical support, and the specific MedVi promotional structure. Choose Direct Meds if you want access to tirzepatide or sublingual options, a lower promotional headline price, and transparent no-membership messaging. MedVi vs Directmeds: pick based on whether the specific medication options or the no-clinic 24/7 support and promotional pricing matter more for your plan.